Zebrafish Assays for Identifying Potential Muscular Dystrophy Drug Candidates - Zebrafish: Methods for Assessing Drug Safety and Toxicity - page 247

meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates
into most mesodermal tissues. Development 129(11): 2773-2783.
M INETTI GC, C OLUSSI C, A DAMI R, S ERRA C, M OZZETTA C, P ARENTE V, F ORTUNI S, S TRAINO S, S AMPAOLESI M, DI
P ADOVA M, I LLI B, G ALLINARI P, S TEINKUHLER C, C APOGROSSI MC, S ARTORELLI V, B OTTINELLI R, G AETANO C,
and P URI PL (2006). Functional and morphological recovery of dystrophic muscles in mice treated with
deacetylase inhibitors. Nat Med 12(10): 1147-1150.
M IZUNO Y, N OGUCHI S, Y AMAMOTO H, Y OSHIDA M, N ONAKA I, H IRAI S, and O ZAWA E (1995). Sarcoglycan
complex is selectively lost in dystrophic hamster muscle. Am J Pathol 146(2): 530-536.
N AKAE Y, H IRASAKA K, G OTO J, N IKAWA T, S HONO M, Y OSHIDA M, and S TOWARD PJ (2008). Subcutaneous
injection, frombirth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular
dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological
study. Histochem Cell Biol 129(4): 489-501.
N ASEVICIUS A and E KKER SC (2000). Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26(2):
216-220.
P ARSONS MJ, C AMPOS I, H IRST EM, and S TEMPLE DL (2002). Removal of dystroglycan causes severemuscular
dystrophy in zebrafish embryos. Development 129(14): 3505-3512.
P ARTRIDGE TA, M ORGAN JE, C OULTON GR, H OFFMAN EP, and K UNKEL LM (1989). Conversion of mdx
myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337(6203):
176-179.
P EI DS, S UN YH, L ONG Y, and Z HU ZY (2007). Inhibition of no tail (ntl) gene expression in zebrafish by
external guide sequence (EGS) technique. Mol Biol Rep 35(2): 139-143.
R ANDO TA, D ISATNIK MH, Y U Y, and F RANCO A (1998). Muscle cells from mdx mice have an increased
susceptibility to oxidative stress. Neuromuscul Disord 8(1): 14-21.
R ANDO TA, D ISATNIK MH, and Z HOU LZ (2000). Rescue of dystrophin expression in mdx mouse muscle by
RNA/DNA oligonucleotides. Proc Natl Acad Sci USA 97(10): 5363-5368.
R OBU ME, L ARSON JD, N ASEVICIUS A, B EIRAGHI S, B RENNER C, F ARBER SA, and E KKER SC (2007). p53
activation by knockdown technologies. PLoS Genet 3(5): e78.
R ODRIGUEZ MC and T ARNOPOLSKY MA (2003). Patients with dystrophinopathy show evidence of increased
oxidative stress. Free Radic Biol Med 34(9): 1217-1220.
R OMERO NB, B RAUN S, B ENVENISTE O, L ETURCQ F, H OGREL JY, M ORRIS GE, B AROIS A, E YMARD B, P AYAN C,
O RTEGA V, B OCH AL, L EJEAN L, T HIOUDELLET C, M OUROT B, E SCOT C, C HOQUEL A, R ECAN D, K APLAN JC,
D ICKSON G, K LATZMANN D, M OLINIER -F RENCKEL V, G UILLET JG, S QUIBAN P, H ERSON S, and F ARDEAU M
(2004). Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular
dystrophy. Hum Gene Ther 15(11): 1065-1076.
R YBAKOVA IN, P ATEL JR, D AVIES KE, Y URCHENCO PD, and E RVASTI JM (2002). Utrophin binds laterally along
actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-
deficient muscle. Mol Biol Cell 13(5): 1512-1521.
R YBAKOVA IN, P ATEL JR, and E RVASTI JM (2000). The dystrophin complex forms a mechanically strong link
between the sarcolemma and costameric actin. J Cell Biol 150(5): 1209-1214.
S ANNER BM, M EDER U, Z IDEK W, and T EPEL M (2002). Effects of glucocorticoids on generation of reactive
oxygen species in platelets. Steroids 67(8): 715-719.
S KROMNE I and P RINCE VE (2008). Current perspectives in zebrafish reverse genetics: moving forward. Dev
Dyn 237(4): 861-882.
S KUK D, G OULET M, R OY B, C HAPDELAINE P, B OUCHARD JP, R OY R, D UGRE FJ, S YLVAIN M, L ACHANCE JG,
D ESCHENES L, S ENAY H, and T REMBLAY JP (2006). Dystrophin expression in muscles of Duchenne
muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp
Neurol 65(4): 371-386.
S KUK D, R OY B, G OULET M, C HAPDELAINE P, B OUCHARD JP, R OY R, D UGRE FJ, L ACHANCE JG, D ESCHENES L,
H ELENE S, S YLVAIN M, and T REMBLAY JP (2004). Dystrophin expression in myofibers of Duchenne
muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther
9(3): 475-482.
T AVERNA D, D ISATNIK MH, R AYBURN H, B RONSON RT, Y ANG J, R ANDO TA, and H YNES RO (1998). Dystrophic
muscle in mice chimeric for expression of alpha5 integrin. J Cell Biol 143(3): 849-859.